InvestSMART

Immutep Limited (ASX: IMM) - Announcements

- Current share price for IMM : $0.041

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$60 Change in substantial holding 5 Feb 2026 8:15AM $0.385 $0.041 fallen by 89.35%
$60 Immutep Quarterly Activities Report and Appendix 4C 29 Jan 2026 11:36AM $0.425 $0.041 fallen by 90.35%
$60 Change in substantial holding 31 Dec 2025 8:27AM $0.430 $0.041 fallen by 90.47%
$60 Positive Update on IMP761 Phase 1 22 Dec 2025 8:25AM $0.395 $0.041 fallen by 89.62%
$60 TACTI-004 phase III trial enrolment continues at robust pace 16 Dec 2025 8:34AM $0.370 $0.041 fallen by 88.92%
$60 Immutep enters into Strategic Collaboration with Dr. Reddy's 8 Dec 2025 6:24PM $0.255 $0.041 fallen by 83.92%
$60 Change of Director's Interest Notice - R Howard 5 Dec 2025 7:34PM $0.260 $0.041 fallen by 84.23%
$60 Change of Director's Interest Notice - P Meyers 5 Dec 2025 7:28PM $0.260 $0.041 fallen by 84.23%
$60 Change of Director's Interest Notice - L Boyce 5 Dec 2025 7:27PM $0.260 $0.041 fallen by 84.23%
$60 Application for quotation of securities - IMM 5 Dec 2025 9:56AM $0.255 $0.041 fallen by 83.92%
$60 Notification regarding unquoted securities - IMM 2 Dec 2025 11:56AM $0.293 $0.041 fallen by 85.98%
$60 New data presentation from AIPAC-003 Phase II for SABCS 2 Dec 2025 9:29AM $0.295 $0.041 fallen by 86.10%
$60 Results of Meeting 27 Nov 2025 1:13PM $0.293 $0.041 fallen by 85.98%
$60 Immutep AGM 2025 - Chairman's Address 27 Nov 2025 10:51AM $0.285 $0.041 fallen by 85.61%
$60 Immutep AGM 2025 - CEO's Presentation 27 Nov 2025 10:47AM $0.285 $0.041 fallen by 85.61%
$60 EFTISARC-NEO Phase II results presented at CTOS 2025 13 Nov 2025 8:18AM $0.270 $0.041 fallen by 84.81%
$60 Immutep Receives A$4.6 million French R&D Tax Incentive 3 Nov 2025 9:28AM $0.280 $0.041 fallen by 85.36%
$60 Immutep Quarterly Activities Report and Appendix 4C 29 Oct 2025 8:22AM $0.285 $0.041 fallen by 85.61%
$60 Annual Report filed on Form 20-F 27 Oct 2025 8:15AM $0.305 $0.041 fallen by 86.56%
$60 Notice of Annual General Meeting/Proxy Form 24 Oct 2025 8:31AM $0.295 $0.041 fallen by 86.10%
$60 Appendix 4G and Corporate Governance Statement 24 Oct 2025 8:31AM $0.295 $0.041 fallen by 86.10%
$60 Annual Report to shareholders 24 Oct 2025 8:31AM $0.295 $0.041 fallen by 86.10%
$60 Improved ORR in First Line NSCLC - presented at ESMO 2025 20 Oct 2025 8:17AM $0.305 $0.041 fallen by 86.56%
$60 Primary Endpoint Met in STS Trial - presented at ESMO 2025 20 Oct 2025 8:17AM $0.305 $0.041 fallen by 86.56%
$60 2025 Annual General Meeting and Key Dates 15 Oct 2025 8:32AM $0.290 $0.041 fallen by 85.86%

51 - 75 of 780 results

Page 3 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.